Wu W-B, Zhang X-B, Liu Y-P, Zou X, You R, Xie Y-L, Duan X-T, Li H-F, Wen K, Peng L, Hua Y-J, Huang P-Y, Sun R, Chen J-H, Chen M-Y
Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Center, Guangzhou, P. R. China.
Sun Yat-sen University Cancer Center.
Rhinology. 2023 Jan 30. doi: 10.4193/Rhin22.451.
Post radiation nasopharyngeal necrosis (PRNN) invading the internal carotid artery (ICA) contributes to the death of 69.2-72.7% of PRNN patients. ICA occlusion is an effective treatment to avoid fatal bleeding, while some patients are intolerant. We present a novel method that allows for these patients without interrupting blood flow through the ICA.
This study enrolled patients with PRNN-invaded ICA who were not suitable for ICA occlusion from April 2020 to November 2022. ICA stent pretreatment was performed in the 36 patients and followed the endoscopic nasopharyngectomy (ENPG) or conservative treatment for PRNN. We report the survival outcome and incidence of complications after stent implantation and compare the survival outcomes of ENPG and conservative treatment for PRNN followed by stent implantation.
ICA stent pretreatment was performed in the 36 enrolled patients, among which 14 underwent ENPG, and 22 received conservative treatment. 27.8% patients died after a median follow-up of 15 months. The Kaplan-Meier estimates of overall survival were higher in the ENPG group than in the conservative treatment group. Karnofsky performance status (KPS) was significantly higher in the ENPG group than in the non-ENPG group.
The innovative application of ICA stents is a promising treatment to improve outcomes in patients with PRNN invading the ICA who are unsuitable for ICA embolization, especially when followed by endoscopic surgery. However, methods to avoid postoperative cerebral ischemia and nasopharyngeal hemorrhage still require further study.
放射性后鼻咽坏死(PRNN)侵犯颈内动脉(ICA)导致69.2%-72.7%的PRNN患者死亡。ICA闭塞是避免致命性出血的有效治疗方法,但部分患者无法耐受。我们提出一种新方法,可用于这些患者,且不中断通过ICA的血流。
本研究纳入了2020年4月至2022年11月期间因PRNN侵犯ICA而不适合进行ICA闭塞的患者。对36例患者进行了ICA支架预处理,随后进行了鼻内镜下鼻咽癌切除术(ENPG)或PRNN的保守治疗。我们报告了支架植入后的生存结局和并发症发生率,并比较了ENPG和PRNN保守治疗后再行支架植入的生存结局。
36例纳入患者均进行了ICA支架预处理,其中14例行ENPG,22例接受保守治疗。中位随访15个月后,27.8%的患者死亡。ENPG组的总生存Kaplan-Meier估计值高于保守治疗组。ENPG组的卡诺夫斯基功能状态(KPS)显著高于非ENPG组。
ICA支架的创新应用是一种有前景的治疗方法,可改善因PRNN侵犯ICA而不适合进行ICA栓塞的患者的预后,尤其是在内镜手术后。然而,避免术后脑缺血和鼻咽出血的方法仍需进一步研究。